The global Topical Non-Steroidal Anti-Inflammatory Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime, Inc. (LPI) ' newest research report, the “Topical Non-Steroidal Anti-Inflammatory Drugs Industry Forecast” looks at past sales and reviews total world Topical Non-Steroidal Anti-Inflammatory Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Topical Non-Steroidal Anti-Inflammatory Drugs sales for 2024 through 2030. With Topical Non-Steroidal Anti-Inflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Non-Steroidal Anti-Inflammatory Drugs industry.

This Insight Report provides a comprehensive analysis of the global Topical Non-Steroidal Anti-Inflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Topical Non-Steroidal Anti-Inflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical Non-Steroidal Anti-Inflammatory Drugs market.

Key Features

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Non-Steroidal Anti-Inflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Non-Steroidal Anti-Inflammatory Drugs.

Segmentation by Type

• Gel
• Cream
• Liquid Spray
• Paste
• Other

Segmentation by Application

• Skin Inflammation
• Arthritis
• Sprains
• Everyday Injuries
• Other

Market by Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Company's Coverage

• Roche
• Viatris
• Teva Pharmaceutical Industries
• Sanofi
• Pfizer
• GlaxoSmithKline
• Novartis
• Zydus Cadila
• Boehringer Ingelheim International
• Apotex
• AstraZeneca
• Horizon Therapeutics
• Johnson & Johnson
• Bayer
• Perrigo Company
• Tolmar Pharmaceuticals
• Sun Pharmaceutical Industries
• Assertio Therapeutics
• Daiichi Sankyo

Key Questions Addressed in this Report

1. What is the 10-year outlook for the global Topical Non-Steroidal Anti-Inflammatory Drugs market?
2. What factors are driving Topical Non-Steroidal Anti-Inflammatory Drugs market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Topical Non-Steroidal Anti-Inflammatory Drugs market opportunities vary by end market size?
5. How does Topical Non-Steroidal Anti-Inflammatory Drugs break out by Type, by Application?